Stay updated with the latest health news and analysis
New heart disease guidelines dramatically lower the age for proactive cholesterol management, now recommending individuals as young as 30 consider lifestyle changes and, in some cases, statins. This significant update aims to prevent future heart attacks and strokes by addressing high LDL cholesterol and family history much earlier than previous recommendations.
A concerning social media trend called "looksmaxxing" is pushing boys and men to undertake extreme measures, including plastic surgery and steroid use, to drastically alter their physical appearance. Experts and parents are now raising alarms about the potential for severe negative body image and low self-esteem fueled by such practices, even extending to dangerous "facial bone smashing.
India's Supreme Court has surprisingly cautioned against a mandatory menstrual leave law, fearing it could actually harm young women's career opportunities by making employers hesitant to hire or promote them. Rejecting a nationwide mandate, the court suggested voluntary policies are preferable, warning that a legal requirement might unintentionally reinforce gender stereotypes and limit professional advancement.
Scientists have identified a newly discovered gene switch that could make chemotherapy-resistant pancreatic cancer treatable, offering a significant breakthrough against one of the most aggressive and difficult cancers. This exciting finding aims to transform previously untreatable forms of the disease into ones responsive to existing therapies, bringing new hope to patients.
A new study projects a staggering rise in global breast cancer diagnoses, exceeding 3.5 million annually by 2050, signaling a major worldwide health crisis. This alarming increase is compounded by growing mortality rates in low-income countries, underscoring the urgent need for improved healthcare infrastructure and comprehensive management strategies globally.
A devastating explosion at an ammunition manufacturing company in Raulgaon village, Maharashtra's Nagpur district, tragically killed at least 17 people. This catastrophic incident also left 18 others injured and receiving urgent medical treatment, underscoring the severe risks associated with such industrial facilities.
Scientists have developed a groundbreaking new toothpaste specifically designed to combat severe gum disease, periodontitis, offering a precise solution for oral health. This innovative formula uniquely targets harmful bacteria without disrupting beneficial oral microbes, promising a revolutionary and more effective treatment than current methods.
Prime Minister Narendra Modi has launched a landmark nationwide Human Papillomavirus (HPV) vaccination campaign in Ajmer, Rajasthan, targeting 14-year-old girls across India. This crucial initiative aims to significantly reduce cervical cancer rates, showcasing India's strong commitment to preventive healthcare for its young female population.
The Canadian Paediatric Society now recommends universal cholesterol screening for all children aged two to ten, aiming to detect early atherosclerosis and prevent future heart disease. This proactive measure allows for timely interventions, including lifestyle changes, to manage cholesterol levels and significantly reduce the risk of serious cardiovascular issues in adulthood.
Mexican security forces have killed "El Mencho," the notorious leader of the Jalisco New Generation Cartel and one of the world's most wanted drug traffickers, delivering a significant blow to the powerful criminal organization. This high-profile operation in Jalisco has, however, ignited a wave of retaliatory violence across several Mexican states, causing widespread disruption, school cancellations, and urgent travel warnings.
Stanford Medicine researchers have developed a groundbreaking universal nasal spray vaccine designed to offer broad protection against various respiratory threats, including viruses, bacteria, and allergens. This innovative vaccine works by supercharging the lungs' immune defenses, significantly reducing viral levels, preventing severe illness, and blocking allergic reactions in mouse studies.
Major advancements in infectious disease prevention are on the horizon, as Merck unveiled positive Phase 3 trial results for its RSV treatment, clesrovimab, aimed at protecting high-risk young children, and GSK presented new real-world effectiveness data for its Arexvy vaccine. Adding to these developments, the FDA has reversed its decision and will now review Moderna's investigational mRNA-1010 influenza vaccine, signaling a crucial step for its potential approval.